Literature DB >> 18033858

Autoimmune diseases. The B cell slayer.

Robert Matthews.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033858     DOI: 10.1126/science.318.5854.1232

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

Review 1.  Development of antibody surrogates for the treatment of cancers and autoimmune disease.

Authors:  Thomas Kodadek
Journal:  Curr Opin Chem Biol       Date:  2010-07-31       Impact factor: 8.822

Review 2.  The emerging field of osteoimmunology.

Authors:  Kofi A Mensah; Jie Li; Edward M Schwarz
Journal:  Immunol Res       Date:  2009-01-30       Impact factor: 2.829

Review 3.  Siglecs as targets for therapy in immune-cell-mediated disease.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Trends Pharmacol Sci       Date:  2009-04-07       Impact factor: 14.819

4.  Dextran as a generally applicable multivalent scaffold for improving immunoglobulin-binding affinities of peptide and peptidomimetic ligands.

Authors:  Jumpei Morimoto; Mohosin Sarkar; Sophia Kenrick; Thomas Kodadek
Journal:  Bioconjug Chem       Date:  2014-07-30       Impact factor: 4.774

Review 5.  The Akt pathway in oncology therapy and beyond (Review).

Authors:  George Mihai Nitulescu; Maryna Van De Venter; Georgiana Nitulescu; Anca Ungurianu; Petras Juzenas; Qian Peng; Octavian Tudorel Olaru; Daniela Grădinaru; Aristides Tsatsakis; Dimitris Tsoukalas; Demetrios A Spandidos; Denisa Margina
Journal:  Int J Oncol       Date:  2018-10-16       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.